Wealth Enhancement Advisory Services LLC Purchases Shares of 13,384 Quantum-Si Incorporated (NASDAQ:QSI)

Wealth Enhancement Advisory Services LLC purchased a new stake in Quantum-Si Incorporated (NASDAQ:QSI) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 13,384 shares of the company’s stock, valued at approximately $36,000.

A number of other large investors have also recently bought and sold shares of the stock. Rhumbline Advisers boosted its stake in Quantum-Si by 3.7% in the fourth quarter. Rhumbline Advisers now owns 148,946 shares of the company’s stock worth $402,000 after purchasing an additional 5,298 shares in the last quarter. Mariner LLC boosted its stake in Quantum-Si by 29.1% in the fourth quarter. Mariner LLC now owns 33,439 shares of the company’s stock worth $90,000 after purchasing an additional 7,540 shares in the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its stake in Quantum-Si by 29.4% in the fourth quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 33,902 shares of the company’s stock worth $92,000 after purchasing an additional 7,704 shares in the last quarter. Wells Fargo & Company MN boosted its stake in Quantum-Si by 13.9% in the fourth quarter. Wells Fargo & Company MN now owns 71,980 shares of the company’s stock worth $194,000 after purchasing an additional 8,802 shares in the last quarter. Finally, ProShare Advisors LLC boosted its stake in Quantum-Si by 49.0% in the fourth quarter. ProShare Advisors LLC now owns 28,204 shares of the company’s stock worth $76,000 after purchasing an additional 9,280 shares in the last quarter. 39.90% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Alliance Global Partners reissued a “buy” rating on shares of Quantum-Si in a research note on Friday, May 16th. National Bankshares set a $3.65 target price on Quantum-Si in a research report on Wednesday, March 5th. Finally, HC Wainwright restated a “buy” rating and set a $5.50 target price on shares of Quantum-Si in a research report on Monday, May 19th.

Quantum-Si Stock Up 4.2%

QSI stock opened at $1.75 on Thursday. The company has a market cap of $321.13 million, a P/E ratio of -2.57 and a beta of 2.87. Quantum-Si Incorporated has a twelve month low of $0.61 and a twelve month high of $5.77. The business has a fifty day moving average of $1.47 and a 200-day moving average of $1.70.

Quantum-Si (NASDAQ:QSI) last released its earnings results on Thursday, May 15th. The company reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.17) by $0.06. The company had revenue of $0.84 million during the quarter, compared to the consensus estimate of $0.96 million. Quantum-Si had a negative return on equity of 41.44% and a negative net margin of 2,925.41%. As a group, equities research analysts anticipate that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.

Insider Transactions at Quantum-Si

In related news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the company’s stock in a transaction dated Friday, March 21st. The stock was sold at an average price of $1.39, for a total value of $32,952.73. Following the completion of the sale, the chief executive officer now owns 2,646,716 shares in the company, valued at approximately $3,678,935.24. This represents a 0.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders sold a total of 36,650 shares of company stock worth $50,944 over the last 90 days. 30.04% of the stock is owned by insiders.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.